FPAS
RMD icon

Focus Partners Advisor Solutions’s ResMed RMD Stock Holding History

Focus Partners Advisor Solutions’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,154
Closed -$297K – 1262
2025
Q2 		$297K Sell
1,154
-688
-37% -$164K ﹤0.01% 866
2025
Q1 		$412K Sell
1,842
-136
-7% -$31.8K 0.01% 646
2024
Q4 		$452K Buy
1,978
+352
+22% +$84.8K 0.01% 497
2024
Q3 		$397K Buy
+1,626
New +$363K 0.01% 497

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Focus Partners Advisor Solutions's RMD Position: Q3 2025 in Review

Focus Partners Advisor Solutions sold out of ResMed (RMD) in Q3 2025, closing a stake of 1,154 shares — an estimated $297K sold.

Focus Partners Advisor Solutions first reported a position in RMD in Q3 2024 and held it in 4 quarters. The position peaked at $452K in Q4 2024. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Focus Partners Advisor Solutions reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 1,154 ResMed shares in Q3 2025, an estimated $297K.
  • Focus Partners Advisor Solutions first reported a position in ResMed in Q3 2024 and held it in 4 quarters.
  • Focus Partners Advisor Solutions's ResMed position peaked at $452K in Q4 2024.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Focus Partners Advisor Solutions's 13F filing for Q3 2025, filed 12 Nov 2025.